Literature DB >> 24721633

Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: implications in transitional care.

Anthony P Y Liu1, Pak-Cheong Chow2, Pamela P W Lee1, Gary T K Mok1, Wing-Fai Tang3, Elizabeth T Lau4, Stephen T S Lam5, Kelvin Y Chan4, Anita S Y Kan4, Adolphus K T Chau2, Yiu-Fai Cheung1, Yu-Lung Lau1, Brian H Y Chung6.   

Abstract

22q11.2 deletion syndrome (22q11.2DS) is a multi-systemic disorder with high phenotypic variability. Under-diagnosis in adults is common and recognition of facial dysmorphic features can be affected by age and ethnicity. This study aims to determine the prevalence of undiagnosed 22q11.2DS in adult Chinese patients with conotruncal anomalies and to delineate their facial dysmorphisms and extra-cardiac manifestations. We recruited consecutively 156 patients with conotruncal anomalies in an adult congenital heart disease (CHD) clinic in Hong Kong and screened for 22q11.2DS using fluorescence-PCR and fluorescence in-situ hybridization. Assessment for dysmorphic features was performed by a cardiologist at initial screening and then by a clinical geneticist upon result disclosure. Clinical photographs were taken and childhood photographs collected. Eighteen patients (11.5%) were diagnosed with 22q11.2DS, translating into 1 previously unrecognized diagnosis of 22q11.2DS in every 10 adult patients with conotruncal anomalies. While dysmorphic features were detected by our clinical geneticist in all patients, only two-thirds were considered dysmorphic by our cardiologist upon first assessment. Evolution of facial dysmorphic features was noted with age. Extra-cardiac manifestations included velopharyngeal incompetence or cleft palate (44%), hypocalcemia (39%), neurodevelopmental anomalies (33%), thrombocytopenia (28%), psychiatric disorders (17%), epilepsy (17%) and hearing loss (17%). We conclude that under-diagnosis of 22q11.2DS in Chinese adults with conotruncal defects is common and facial dysmorphic features may not be reliably recognized in the setting of adult CHD clinic, referral for genetic evaluation and molecular testing for 22q11.2DS should be offered to patients with conotruncal defects.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  22q11.2 deletion syndrome (22q11.2DS); Adult; Chinese; Congenital heart disease; Conotruncal anomaly; Dysmorphism

Mesh:

Year:  2014        PMID: 24721633     DOI: 10.1016/j.ejmg.2014.03.014

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  Elucidating the diagnostic odyssey of 22q11.2 deletion syndrome.

Authors:  Lisa D Palmer; Nancy J Butcher; Erik Boot; Kathleen A Hodgkinson; Tracy Heung; Eva W C Chow; Alina Guna; T Blaine Crowley; Elaine Zackai; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-04       Impact factor: 2.802

2.  TBX1 loss-of-function mutation contributes to congenital conotruncal defects.

Authors:  Min Zhang; Fu-Xing Li; Xing-Yuan Liu; Jing-Yi Hou; Shi-Hong Ni; Juan Wang; Cui-Mei Zhao; Wei Zhang; Ye Kong; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

3.  22q11.2 deletion syndrome in diverse populations.

Authors:  Paul Kruszka; Yonit A Addissie; Daniel E McGinn; Antonio R Porras; Elijah Biggs; Matthew Share; T Blaine Crowley; Brian H Y Chung; Gary T K Mok; Christopher C Y Mak; Premala Muthukumarasamy; Meow-Keong Thong; Nirmala D Sirisena; Vajira H W Dissanayake; C Sampath Paththinige; L B Lahiru Prabodha; Rupesh Mishra; Vorasuk Shotelersuk; Ekanem Nsikak Ekure; Ogochukwu Jidechukwu Sokunbi; Nnenna Kalu; Carlos R Ferreira; Jordann-Mishael Duncan; Siddaramappa Jagdish Patil; Kelly L Jones; Julie D Kaplan; Omar A Abdul-Rahman; Annette Uwineza; Leon Mutesa; Angélica Moresco; María Gabriela Obregon; Antonio Richieri-Costa; Vera L Gil-da-Silva-Lopes; Adebowale A Adeyemo; Marshall Summar; Elaine H Zackai; Donna M McDonald-McGinn; Marius George Linguraru; Maximilian Muenke
Journal:  Am J Med Genet A       Date:  2017-04       Impact factor: 2.802

Review 4.  Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.

Authors:  Soma Jyonouchi; Artemio M Jongco; Jennifer Puck; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

5.  Prenatal diagnosis of rearrangements in the fetal 22q11.2 region.

Authors:  Suping Li; Yuxia Jin; Jing Yang; Li Yang; Ping Tang; Chiyan Zhou; Liping Wu; Jinhua Dong; Jie Chen; Huaxiang Shen
Journal:  Mol Cytogenet       Date:  2020-07-08       Impact factor: 2.009

Review 6.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

7.  PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome.

Authors:  Cui-Mei Zhao; Lu-Ying Peng; Li Li; Xing-Yuan Liu; Juan Wang; Xian-Ling Zhang; Fang Yuan; Ruo-Gu Li; Xing-Biao Qiu; Yi-Qing Yang
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

8.  De novo large rare copy-number variations contribute to conotruncal heart disease in Chinese patients.

Authors:  Christopher C Y Mak; Pak Cheong Chow; Anthony P Y Liu; Kelvin Y K Chan; Yoyo W Y Chu; Gary T K Mok; Gordon K C Leung; Kit San Yeung; Adolphus K T Chau; Chelsea Lowther; Stephen W Scherer; Christian R Marshall; Anne S Bassett; Brian H Y Chung
Journal:  NPJ Genom Med       Date:  2016-09-14       Impact factor: 8.617

9.  Gene-by-gene interactions associated with the risk of conotruncal heart defects.

Authors:  Chen Lyu; Daniel M Webber; Stewart L MacLeod; Charlotte A Hobbs; Ming Li
Journal:  Mol Genet Genomic Med       Date:  2019-12-18       Impact factor: 2.183

10.  CNVs in the 22q11.2 Chromosomal Region Should Be an Early Suspect in Infants with Congenital Cardiac Disease.

Authors:  Tatiana Pineda; Ignacio Zarante; Angela Camila Paredes; Juan Pablo Rozo; Martha C Reyes; Olga María Moreno-Niño
Journal:  Clin Med Insights Cardiol       Date:  2021-05-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.